Bayer's PI3K Inhibitor Receives FDA Priority Review for Follicular Lymphoma
The FDA has granted Bayer’s copanlisib a Priority Review designation for its New Drug Application (NDA) to treat relapsed or refractory follicular lymphoma patients
Less than 2 weeks after getting FDA approval for a rare form of lung cancer, Alunbrig (brigatinib) is now available via Biologics, a special oncology pharmacy division of McKesson Specialty Health.
In the past, getting children to stay still for radiation therapy often required general anesthesia. Not anymore – Letting them watch Spongebob or Cars could be all it takes.
Dr Anthony Herbert talks about palliative care specialists in urban areas provide education to health professionals in non-urban areas about palliative care.
Platelet Disorders Support Association (PDSA) provides information for both clinicians and patients to better manage immune thrombocytopenia (ITP).
James Bussel, MD talks about immune thrombocytopenia (ITP) in children, its treatment and some of the data presented at ASPHO's 20th Annual Meeting in Montreal.
Communication is fundamental for delivering medical care. Not all health professionals are properly trained to converse about pediatric palliative care.
Clinical trial shows that the administration of sodium thiosulfate (STS) in pediatric cancer patients receiving cisplatin reduced developing hearing loss.
Valeria Smith M.D. of Baylor College of Medicine Pediatrics provides a retrospective chart review about where pediatric cancer patients die.
Sodium thiosulfate (STS) is a water-soluble thiol compound and a chemical reducing agent. Administration of STS protects against platinum-induced ototoxicity.
$vacMongoViewPlus$ $vAR$